Clinical Trial

Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is an open-label study in adults to determine feasibility of using CYTALUX™ (pafolacianine) injection with near-infrared (NIR) fluorescent imaging for detecting any type adenocarcinoma (gastric, esophageal and appendiceal).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-08.
Status change: Not Yet Recruiting → Recruiting 2025-09-09
Trial Details
NCT Number NCT07124351
Lead Sponsor Cedars-Sinai Medical Center
Collaborators: On Target Laboratories, LLC
Conditions Gastrointestinal Cancer, Gastric Cancer, Esophageal Cancer, Appendiceal Cancer
Enrollment 15 participants
Start Date 2025-09-05
Primary Completion 2026-08 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-09-15